10x Genomics, Inc.TXGNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank63
3Y CAGR-0.5%
5Y CAGR+11.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-0.5%/yr
vs +42.8%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-43.4pp
Decelerating
Percentile
P63
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $554.77M | -8.9% |
| 2024 | $609.04M | -9.7% |
| 2023 | $674.64M | +19.6% |
| 2022 | $563.97M | +20.2% |
| 2021 | $469.31M | +44.1% |
| 2020 | $325.70M | +52.2% |
| 2019 | $213.93M | +57.9% |
| 2018 | $135.47M | +71.7% |
| 2017 | $78.90M | - |